ClinConnect ClinConnect Logo
Search / Trial NCT06938191

Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples

Launched by KIRIKKALE UNIVERSITY · Apr 20, 2025

Trial Information

Current as of July 21, 2025

Not yet recruiting

Keywords

Healthy Pulp Pulpitis Irreversible Pulpitis Aquaporin 4 Il 8 Aquaporin 5 Aquaporin 9

ClinConnect Summary

This clinical trial is studying the levels of specific proteins (called Aquaporins and IL-8) in different types of dental tissue and fluids. The researchers want to see how these levels change in people with healthy teeth compared to those with a painful condition known as irreversible pulpitis, which is a serious inflammation of the tooth pulp. The goal is to understand if there is a connection between these protein levels and the state of the teeth.

To participate in this study, you must be between 18 and 64 years old and scheduled for routine root canal treatment at the Kırıkkale University Dental School. You should not have any known health issues or be pregnant. Participants will provide samples of dental tissue and fluids before their treatment begins, and these will be tested in a lab. This research could help improve our understanding of dental health and how to better treat conditions like pulpitis in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 to 64 years.
  • Patients without any known systemic disease.
  • Patients requiring root canal treatment for prosthetic purposes (Healthy pulp group).
  • Patients with third molars (wisdom teeth) indicated for extraction due to orthodontic or other clinical reasons (Healthy pulp group).
  • Patients diagnosed with symptomatic irreversible pulpitis based on the criteria established by the American Association of Endodontists (AAE) (Symptomatic irreversible pulpitis group).
  • Patients scheduled for routine root canal treatment at the Department of Endodontics, Faculty of Dentistry, Kırıkkale University.
  • Patients who have provided written informed consent to participate in the study.
  • Exclusion Criteria:
  • Patients with any known systemic disease.
  • Pregnant women or those suspected of being pregnant.
  • Patients who have used antibiotics, anti-inflammatory drugs, or antidepressants within the past 4 weeks.
  • Patients with significant dental plaque or calculus, gingival redness or bleeding, severe gingivitis, generalized periodontitis, or periodontal pockets deeper than 4 mm.
  • Patients with teeth showing internal or external root resorption.
  • Patients for whom complete rubber dam isolation cannot be achieved.
  • Patients with teeth exhibiting signs of necrosis, apical lesions, swelling, or presence of a sinus tract.
  • Patients with immature teeth presenting open apices.
  • Patients with third molars (wisdom teeth) that are not fully erupted or have been previously diagnosed with pericoronitis.

About Kırıkkale University

Kırıkkale University is a distinguished academic institution based in Turkey, recognized for its commitment to advancing medical research and education. The university actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. With a focus on innovation and collaboration, Kırıkkale University leverages its multidisciplinary expertise to conduct rigorous clinical studies that address pressing health challenges. Its research initiatives are guided by ethical standards and a dedication to improving patient care through evidence-based findings.

Locations

Patients applied

0 patients applied

Trial Officials

TANSU M BEŞPARMAK, PhD student

Principal Investigator

Kirikkale University, Faculty of Dentistry

ALİ ERDEMİR, PROF

Study Chair

Kirikkale University, Faculty of Dentistry

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported